HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 07-18-2008, 12:58 PM   #1
Del
Member
 
Join Date: Jul 2008
Location: Ontario, Canada
Posts: 18
Anyone heard of Pazopanib?

I've been lurking on this website for about a year. I have learned so much (much more than from my oncologist!), and appreciate this site very much! The collective experiences and wisdom on this site are priceless. At age 36, I was diagnosed with breast cancer (in April, 2007), with mets to my liver. Eight rounds of taxotere plus herceptin knocked the mets out of my liver, and I am now NED. I just had my 6-month check-up MRI of my liver, and I get the results on Mon. (July 21). I am very nervous that mets have returned, since I've had an inconsistent ache on my right side just below the rib cage (I'm assuming it's my liver) for the past 3 weeks. I called the office of my second opinion doctor, and they said if I have recurred, it is recommended that I join a clinical trial for Pazopanib. I have never heard of this drug, and the internet searches I have done have not revealed much. It doesn't appear that it has been trialled with breast cancer very much (from what I can find out). Has anyone heard of this, or heard of any results with this drug? Of course I'm wondering if I should just try a different chemo (I'm currently on maintenance Herceptin and Tamoxifen). I will talk to my regular onc about all this on Mon, but wondering if any of that collective wisdom can help me? Thanks in advance!!
Del is offline   Reply With Quote
Old 07-18-2008, 01:02 PM   #2
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,778
from the nci cancer.gov site

pazopanib hydrochloride
The hydrochloride salt of a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. Pazopanib selectively inhibits vascular endothelial growth factor receptors (VEGFR)-1, -2 and -3, c-kit and platelet derived growth factor receptor (PDGF-R), which may result in inhibition of angiogenesis in tumors in which these receptors are upregulated. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name: GW786034

it is made by Glaxo and seems to be being tried mainly in kidney cancer, ovarian Cancer, and neuroendocrine tumors (eg Islet cell tumors of the pancreas) so far
Lani is offline   Reply With Quote
Old 07-18-2008, 02:37 PM   #3
Joan M
Senior Member
 
Joan M's Avatar
 
Join Date: Oct 2007
Posts: 1,851
Del, I never heard of Pazopanib, but as Lani pointed out it seems to be an anti-angiogenesis drug.

Here's something about trials with Pazopanib from clinicaltrials.gov:

http://clinicaltrials.gov/ct2/results?term=Pazopanib

If you can find out the name of the trial from your second opinion doc you can look it up for more details.

But perhaps there will be not need to go into a trial after all, and your liver is okay. I'll keep my fingers crossed and pray for good results.

Glad you've been lurking around here (lurkers always welcome)and that the information has helped you.

Best, Joan
__________________
Diagnosed stage 2b in July 2003 (2.3 cm, HER2+, ER-/PR-, 7+ nodes). Treated with mastectomy (with immediate DIEP flap reconstruction), AC + T/Herceptin (off label). Cancer advanced to lung in Jan. 2007 (1 cm nodule). Started Herceptin every 3 weeks. Lung wedge resection April 2007. Cancer recurred in lung April 2008. RFA of lung in August 2008. 2nd annual brain MRI in Oct. 2008 discovered 2.6 cm cystic tumor in left frontal lobe. Craniotomy Oct. 2008 (ER-/PR-/HER2-) followed by targeted radiation (IMRT). Coughing up blood Feb. 2009. Thoractomy July 2009 to cut out fungal ball of common soil fungus (aspergillus) that grew in the RFA cavity (most likely inhaled while gardening). No cancer, only fungus. Removal of tiny melanoma from upper left arm, plus sentinel lymph node biopsy in Feb. 2016. Guardant Health liquid biopsy in Feb. 2016 showed mutations in 4 subtypes of TP53. Repeat of Guardant Health biopsy in Jana. 2021 showed 3 TP53 mutations, BRCA1 mutation and CHEK2 mutation. Invitae genetic testing showed negative for all of these. Living with MBC since 2007. Stopped Herceptin Hylecta (injection) treatment in March 2020. Recent 2021 annual CT of chest, abdomen and pelvis and annual brain MRI showed NED. Praying for NED forever!!
Joan M is offline   Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 01:21 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter